Doctors from the Interdisciplinary Center for Clinical Neuromodulation at the Santa Casa School of Medical Sciences in São Paulo, Brazil; the Neuromodulation Division and Departments of Psychiatry and Bioengineering at UCLA in Los Angeles, CA; the Neuropsychiatric Institute at the Prince of Wales Hospital in Sydney, Australia; and the Institute of Psychiatry in Kolkata, India, put together a study to evaluate how transcranial magnetic stimulation (TMS) affects obsessive-compulsive disorder (OCD).
Published in the Journal of ECT, Volume 32, Number 4, this study pooled data from past studies on TMS for OCD to determine just how effective this treatment is for OCD patients. The research dates back to 2001 and references studies done as recently as 2015.
The doctors who compiled this research concluded that actual TMS was significantly more effective than the “sham” or placebo TMS.
It’s exciting that the research on TMS as a treatment for OCD is so promising. And now that the OCD helmet from Brainsway has been approved by the FDA, more people with OCD will, hopefully, be able to receive this life-changing treatment. If you or a loved one struggles with OCD and would like to learn more about your options for TMS, contact us at Serenity Mental Health Centers to schedule an appointment with a psychiatrist.